MNI

April is Parkinson’s Awareness Month, a time to give special attention to a disease that affects approximately 100,000 Canadians. As a centre for both research and clinical treatment of Parkinson’s disease (PD), the Montreal Neurological Institute and Hospital (The Neuro) offers many specialized services and opportunities to participate in research to PD patients.

Classified as: Parkinson's, Parkinson's disease, Parkinson's awareness month
Category:
Published on: 9 Apr 2018

Stuart Trenholm, who joined The Neuro in 2017 as an assistant professor, has received a Career Development Award from The International Human Frontier Science Program Organization (HFSPO), the only Canadian researcher to receive one this year.  

The  Human  Frontier  Science  Program  is  an  international  program  of  research  support  implemented  by  the HFSPO based in Strasbourg, France. Its aims are to promote intercontinental collaboration and training in cutting-edge, interdisciplinary research focused on the life sciences.

Category:
Published on: 28 Mar 2018

The institute that developed the “Montreal Procedure” continues to be on the cutting edge

The Neuro is recognized worldwide as a leader in epilepsy research and treatment. From the beginning, Neuro founder, Dr. Wilder Penfield, made epilepsy a central focus. He and his colleagues developed a surgical treatment for epilepsy patients known as the “Montreal Procedure,” which today is in use throughout the world. The Neuro became a pioneer in studying epilepsy through the use of electroencephalography (EEG) and magnetic resonance imaging (MRI).

Classified as: epilepsy, Montreal Neurological Institute & Hospital, Wilder Penfield Lecture
Published on: 26 Mar 2018

2017 Québec Science Discovery of the Year Award goes to the cancer-detection probe developed by Kevin Petrecca and Frédéric Leblond

Québec Science magazine’s 25-year tradition continues: every fall, a jury comprised of researchers and journalists selects the top 10 most impressive discoveries in Quebec in the past year and the public is asked to vote to select the winner. This year, a cancer-detection probe was chosen by nearly a third of approximately 4,400 votes cast in the 2017 Discovery of the Year contest.

Classified as: Kevin Petrecca, Frederic Leblond, cancer probe, ramen spectroscopy, Quebec Science, brain cancer, brain tumour
Published on: 19 Mar 2018

Women scientists and clinicians are creators and changemakers, expanding the boundaries of human knowledge

 

The Neuro has launched Neuro XXceptional - an exciting new year-long video series featuring women who tell us what drove them to become scientists and clinicians, and what they love about their work. At The Neuro, these exceptional professionals are improving the lives of patients, helping us understand how the brain works and how to treat neurological disease.

Classified as: Neuro XXceptional, women in science, Heidi McBride, Lesley Fellows
Published on: 8 Mar 2018

Industry and academia to share expertise in effort to develop improved methods to produce and characterize antibodies and reagents for neurological research

Classified as: Thermo Fisher, open science, ALS, Parkinson's disease, ataxia, reagrents
Published on: 5 Mar 2018

You’re about to turn 60, and you’re fretting. Your mother has had Alzheimer’s disease since the age of 65. At what age will the disease strike you? A Canadian study published in JAMA Neurology shows that the closer a person gets to the age at which their parent exhibited the first signs of Alzheimer’s, the more likely they are to have amyloid plaques, the cause of the cognitive decline associated with the disease, in their brain.

Classified as: Alzheimer's disease, Alzheimer's
Published on: 26 Feb 2018

Canadian Open Neuroscience Platform will make disseminating and publishing data easier

Modern neuroscience research can produce massive amounts of data, which researchers can use to find patterns revealing anything from the first physiological signs of Alzheimer’s disease to a new drug target that could stop neurodegeneration. However, this data must be stored, processed, and distributed effectively.

Classified as: neuroinformatics, Alan Evans, CONP, Canadian Open Neuroscience Platform, Brain Canada
Published on: 19 Feb 2018

Volume in brain region linked to physiological changes characteristic of AD

New research has drawn a link between changes in the brain’s anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer’s disease (AD), findings that could one day provide a sensitive but non-invasive test for AD before cognitive symptoms appear.

Classified as: Alzheimer's disease, AD, MRI, Christine Tardif, Mallar Chakravarty, Douglas Institute
Published on: 19 Dec 2017

NeuroSGC created to increase volume and quality of cell assays for drug discovery

A new partnership between the Structural Genomics Consortium (SGC) and the Montreal Neurological Institute and Hospital (The Neuro) will use a unique open science framework to help scientists discover new targets for drug development for neurological diseases.

The partnership, called NeuroSGC, will initially focus on Parkinson’s disease and amyotrophic lateral sclerosis (ALS), two of the most common neurodegenerative diseases.

Classified as: open science, MNI
Published on: 6 Dec 2017

Industry and academia team up for the benefit of people suffering from ALS

A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.

The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.

Classified as: Takeda, stem cells, ALS, hiPSCs, amyotrophic lateral sclerosis, open science, C-BIGR, Open Drug Discovery Platform
Published on: 4 Dec 2017

Senate of Canada recognizes outstanding contributions to the community 

The Senate of Canada has awarded Alan Evans a Canada 150 medal for his commitment to advancements in Alzheimer’s disease and palliative care research. He was nominated by Senator Judith Seidman, a former research fellow at the Montreal Neurological Institute and Hospital, and Associate Professor of the McGill School of Social Work.

Classified as: Alan Evans
Category:
Published on: 27 Nov 2017

Grants for Heather Durham, Stefano Stifani and Jay Ross total just over $2 million 

Three MNI researchers have received grants from the ALS Society of Canada worth a total of more than $2 million.  

Published on: 24 Nov 2017

Brain stimulation can change how much we enjoy and value music

Enjoyment of music is considered a subjective experience; what one person finds gratifying, another may find irritating. Music theorists have long emphasized that although musical taste is relative, our enjoyment of music, be it classical or heavy metal, arises, among other aspects, from structural features of music, such as chord or rhythm patterns that generate anticipation and expectancy.

Classified as: music, Robert Zatorre, Ernest Mas Herrero, fronto-striatal circuits, TMS, transcranial magnetic stimulation
Published on: 20 Nov 2017

The Azrieli Centre for Autism Research will foster innovations in therapy and a better understanding of Autism Spectrum Disorder.

A new research centre in Montreal will help lift the shroud of mystery surrounding autism spectrum disorder (ASD), and lead to the development of better diagnostic tools and more effective therapies for people with autism.

Classified as: Autism Research, Azrieli Foundation, autism
Published on: 23 Oct 2017

Pages